NDC 70518-3582-2 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3582
- Requested NDC
- 70518-3582-2
- Package NDCs from labels
- 70518-3582-2, 70518-3582-0, 70518-3582-5, 70518-3582-4, 70518-3582-3, 70518-3582-6, 70518-3582-8, 70518-3582-7, 70518-3582-1, 70518-3582-9
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2022-12-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-12-27 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | Becton Dickinson and Company | 6e43c5a3-dad2-49ed-b500-964cb4563cc9 | 2024-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | bc8b413f-2f07-4e6a-bb8e-a1f2119ae1cf | 2024-05-30 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Actavis Pharma, Inc. | 5cb4a1db-f32d-44af-8985-0a94ca506468 | 2024-05-30 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Bryant Ranch Prepack | adbcb0f7-0421-47e2-854e-e1cfefb6386f | 2024-05-29 | Warnings, Adverse reactions | 44YRR34555 |
| levetiracetam | LEVETIRACETAM | Mylan Institutional LLC | e86dc508-4d22-493b-bdf1-408b6484d3f1 | 2024-05-28 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Hospira, Inc. | ed1b74a8-2a9b-4315-b051-673c7941cb13 | 2024-05-14 | Warnings, Adverse reactions | 44YRR34555 |
| levetiracetam | LEVETIRACETAM | Baxter Healthcare Corporation | 3d88adda-9580-44bf-b75c-d615c973c1e1 | 2024-05-06 | Warnings, Adverse reactions | 44YRR34555 |
| Fleet | GLYCERIN | C.B. Fleet Company, Inc. | 381f4179-0c3b-41f8-927c-c88534ebe06d | 2024-05-06 | Warnings | PDC6A3C0OX |
| Enviroclenz | BERBERIS VULGARIS, CARDUUS MARIANUS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, LAPPA MAJOR, RHAMNUS FRANGULA, STILLINGIA SYLVATICA, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, GERMANIUM SESQUIOXIDE, PHYTOLACCA DECANDRA, ACETONE, AMMONIUM MURIATICUM, BENZINUM, PROPYLENE GLYCOL, SODIUM LAURYL SULFATE, SODIUM TRIPOLYPHOSPHATE, TEREBINTHINA, METHANOL, CHLORINUM, IRIDIUM METALLICUM, LYCOPODIUM CLAVATUM, NITRICUM ACIDUM, NUX VOMICA, PHOSPHORICUM ACIDUM | Deseret Biologicals, Inc. | 92816bbe-96d6-45fc-9929-d3e6df394a33 | 2024-05-02 | Warnings | 6DC9Q167V3 |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM | Nexus Pharmaceuticals LLC | ee014183-a857-457b-9573-0cc168e560f3 | 2024-04-30 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Camber Pharmaceuticals, Inc. | 63b36274-89f0-42d8-9f09-f9e78e179af4 | 2024-04-29 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | B. Braun Medical Inc. | ad32ec2f-b4e0-4811-8ea1-7a4abdd5c0a6 | 2024-04-23 | Warnings, Adverse reactions | 44YRR34555 |
| PEMF Optimizer | AQUA SULIS, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, LAPIS ALBUS, MANGANUM METALLICUM VANADIUM METALLICUM VISCUM ALBUM, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 97d57469-4c5b-4d3f-9398-3a1a6617a649 | 2024-04-23 | Warnings | 059QF0KO0R |
| levetiracetam | LEVETIRACETAM | Sagent Pharmaceuticals | d2de9565-0c0b-4957-bafa-1a286103709e | 2024-04-18 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam in Sodium Chloride | LEVETIRACETAM IN SODIUM CHLORIDE | Hikma Pharmaceuticals USA Inc. | c723fd27-214c-45f6-b170-a3b807ffab07 | 2024-04-12 | Warnings, Adverse reactions | 44YRR34555 |
| Sterile Water | WATER | Hikma Pharmaceuticals USA Inc. | 78ef7ad3-451d-43d0-a9b6-5cf0aadca003 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | B. Braun Medical Inc. | 8fc8d87a-3951-4ac5-97df-c161ffc90475 | 2024-04-10 | Warnings, Adverse reactions | 059QF0KO0R |
| PREPARATION H Maximum Strength | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | Haleon US Holdings LLC | 7cc03d2e-e708-589a-d9bb-58ebbda989c0 | 2024-04-05 | Warnings | PDC6A3C0OX |
| Levetiracetam | LEVETIRACETAM | Aurobindo Pharma Limited | 2471ee03-d747-4113-86d0-1aa93c8f3eba | 2024-04-04 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Novadoz Pharmaceuticals LLC | 484e8d8f-be40-46f8-a509-d1bbdbbd2981 | 2024-04-04 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.